Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis easlfibronostg on June 26, 2026 Category: Publications Tag: LIVERFASt, MASLD, Monitoring, NAFLD, Steatosis Post navigation Previous: Previous post: Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLDNext: Next post: Comparative Performances of LIVERFASt, Fibroscan and other NITs for severe fibrosis in NAFLD patients (Bordeaux cohort)
